{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T21:11:25Z","timestamp":1772485885204,"version":"3.50.1"},"reference-count":66,"publisher":"Informa UK Limited","issue":"18","funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.2217\/fon-2021-1635","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T08:51:42Z","timestamp":1647334302000},"page":"2173-2191","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Phase II clinical trial of cabozantinib for the treatment of recurrent hepatocellular carcinoma after liver transplantation"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6393-9064","authenticated-orcid":false,"given":"Amirhossein","family":"Azhie","sequence":"first","affiliation":[{"name":"Ajmera Transplant Program,University Health Network,\rToronto,\rOntario,\rM5G 2N2,\rCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C","family":"Grant","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology,Princess Margaret Cancer Centre,University Health Network,University of Toronto,\rToronto,\rOntario,\rM5G 2M9,\rCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Herman","sequence":"additional","affiliation":[{"name":"Oakville Trafalgar Memorial Hospital,\rOakville,\rOntario,\rL6M 0L8,\rCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Wang","sequence":"additional","affiliation":[{"name":"Biostatistics Division, Princess Margaret Cancer Centre,University Health Network,\rToronto,\rM5G 2M9,\rCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J","family":"Knox","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology,Princess Margaret Cancer Centre,University Health Network,University of Toronto,\rToronto,\rOntario,\rM5G 2M9,\rCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1960-8449","authenticated-orcid":false,"given":"Mamatha","family":"Bhat","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Program,University Health Network,\rToronto,\rOntario,\rM5G 2N2,\rCanada"},{"name":"Division of Gastroenterology & Hepatology, Department of Medicine,University of Toronto,\rOntario,\rM5S 1A8,\rCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.11.023"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16494"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i21.2591"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28643"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308513"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20391"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.07.012"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12185"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000965"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.029"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.4_suppl.479"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.022"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0008"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31046-2"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30351-6"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0659"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-019-1316-7"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30207-1"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32453-9"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1717002"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1261"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03357"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0421fje"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2620"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.01.027"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.14604"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.212"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0264"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2018.10.006"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-4001-y"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.09.011"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.4_suppl.261"},{"key":"e_1_3_6_37_1","unstructured":"businesswire Exelixis\u2019 partner Ipsen announces Health Canada\u2019s approval of CABOMETYX\u00ae (cabozantinib) tablets for the treatment of patients with previously treated advanced hepatocellular carcinoma. (2019). www.businesswire.com\/news\/home\/20191112005303\/en\/Exelixis'-Partner-Ipsen-Announces-Health-Canada's-Approval-of-CABOMETYX\u00ae-cabozantinib-Tablets-for-the-Treatment-of-Patients-With-Previously-Treated-Advanced-Hepatocellular-Carcinoma"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2007.39"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e283"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.026"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.09.022"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2012.01540.x"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.06.046"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12150"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328359e550"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyq055"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.11.058"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i39.11185"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2015.01.001"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002955"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15551"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2020.06.002"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22434"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2016.10.006"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2011.12.009"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.112"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0743-2"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-020-05271-3"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-399"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-011-0031-9"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.621"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.7769"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.12.154"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30036"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5931"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.06.011"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_6_68_1","unstructured":"National Cancer Institute . Common Terminology Criteria for Adverse Events (CTCAE) v5.0. 2017. (2019). https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2021-1635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:43:33Z","timestamp":1719125013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2021-1635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":66,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.2217\/fon-2021-1635"],"URL":"https:\/\/doi.org\/10.2217\/fon-2021-1635","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}